scholarly article | Q13442814 |
P2093 | author name string | Long Chen | |
Yinkun Liu | |||
Binbin Zhou | |||
Heng Hu | |||
Huiying Ma | |||
Chunmin Liang | |||
Rilun Li | |||
P2860 | cites work | Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7 | Q24318384 |
Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13 | Q24319684 | ||
A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes | Q24681916 | ||
6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7 | Q24683114 | ||
SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10 | Q24797335 | ||
Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
Role for CCR7 ligands in the emigration of newly generated T lymphocytes from the neonatal thymus | Q28204211 | ||
CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway | Q28209767 | ||
Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis | Q28215582 | ||
Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension | Q28249290 | ||
Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma | Q28584799 | ||
CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs | Q28594485 | ||
An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
Specific and nonspecific immunity in the prevention of spontaneous tumours | Q33702133 | ||
Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes | Q33939602 | ||
Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model | Q34105795 | ||
Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells | Q35810906 | ||
Regulatory T cells and mechanisms of immune system control | Q35852343 | ||
Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein | Q35943644 | ||
The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3 | Q36172008 | ||
Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses | Q36369047 | ||
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction | Q59061007 | ||
Combined chemokine and cytokine gene transfer enhances antitumor immunity | Q71607043 | ||
Eradication of established tumors by CD8+ T cell adoptive immunotherapy | Q74301350 | ||
The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells | Q77320320 | ||
A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity | Q77337846 | ||
CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors | Q77380589 | ||
Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells | Q77785419 | ||
The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells | Q81789751 | ||
CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes | Q82176277 | ||
Certified professionals: CD4(+)CD25(+) suppressor T cells | Q36369181 | ||
CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo | Q36371316 | ||
Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy | Q36380365 | ||
Immune surveillance against a solid tumor fails because of immunological ignorance | Q37178041 | ||
Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts | Q37610441 | ||
Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 Th cells at tumor sites. | Q40073121 | ||
Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant. | Q40383031 | ||
Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. | Q40564039 | ||
Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT. | Q40582098 | ||
Long-term expression of angiostatin suppresses metastatic liver cancer in mice | Q40585480 | ||
Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms | Q40864365 | ||
RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations | Q41174063 | ||
Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo | Q41732041 | ||
Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization | Q42064511 | ||
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity | Q43416597 | ||
T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. | Q43561148 | ||
Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice | Q43996182 | ||
Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue | Q45872828 | ||
Long-term modifications of blood pressure in normotensive and spontaneously hypertensive rats by gene delivery of rAAV-mediated cytochrome P450 arachidonic acid hydroxylase | Q45887484 | ||
In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector | Q45889326 | ||
Secondary lymphoid-tissue chemokine (SLC) stimulates integrin alpha 4 beta 7-mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) under flow. | Q46224027 | ||
Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma | Q46356356 | ||
The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. | Q47915773 | ||
A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells | Q48035864 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 10 | |
P304 | page(s) | 5615-5623 | |
P577 | publication date | 2013-10-01 | |
P1433 | published in | Molecular Biology Reports | Q15752755 |
P1476 | title | The anti-tumor effect and increased tregs infiltration mediated by rAAV-SLC vector | |
P478 | volume | 40 |
Search more.